From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates.
about
Bisphosphonates for osteoarthritisBisphosphonates: from bench to bedsideLaminopathies and the long strange trip from basic cell biology to therapyThe bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in ratsPreclinical evaluation of zoledronate to maintain bone allograft and improve implant fixation in revision joint replacement.Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats.The posttranslational processing of prelamin A and disease.Osteoblastic protein tyrosine phosphatases inhibition and connexin 43 phosphorylation by alendronate.Osteonecrosis of the jaw in a patient on Denosumab.Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromesMechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.Nothing but skin and bone.Osteoblastic cell secretome: a novel role for progranulin during risedronate treatmentDifferences between the bisphosphonates for the prevention and treatment of osteoporosis.CONNEXIN 43 AND BONE: NOT JUST A GAP JUNCTION PROTEIN.Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunitiesThe anti-tumour effects of zoledronic acidExtracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells.Drug insight: Existing and emerging therapies for osteoporosis.Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.Bisphosphonate treatment in the oim mouse model alters bone modeling during growthEffects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films.Genetics of the bone response to bisphosphonate treatmentsTeriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.Zoledronic acid: an unending tale for an antiresorptive agent.Dickkopf-1 as a potential therapeutic target in Paget's disease of bone.Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.Bisphosphonates and connexin 43: a critical review of evidence.Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression.Macrophages and skeletal health.Additive-free albumin nanoparticles of alendronate for attenuating inflammation through monocyte inhibition.Stage 0 osteonecrosis of the jaw in a patient on denosumab.Alendronate-coated long-circulating liposomes containing 99mtechnetium-ceftizoxime used to identify osteomyelitis.Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS).Bisphosphonates and cancer: what opportunities from nanotechnology?Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells.Inhibiting mevalonate pathway enzymes increases stromal cell resilience to a cholesterol-dependent cytolysin.Curculigoside promotes osteogenic differentiation of bone marrow stromal cells from ovariectomized rats.
P2860
Q24202794-177A6A43-2476-47EE-863B-1C6E32B39FFEQ28251212-58609B55-CCA9-44A3-A0DF-2BBA0838A6E9Q28251294-F76AF3AA-EC09-4AEC-AD4D-F25CB119ECEBQ28569481-EAAFC9E4-33E7-4513-95A4-11D3575FF9EAQ30551112-53EE6E2D-EA28-4F6D-A44D-9D2D46DCF4DFQ33252926-A8CD70C6-9965-4EFE-8DF7-91D6D64FE13CQ33758494-7BD1DBE1-9A7A-4AAF-990F-A79501DF61EAQ33827663-0B71C464-FB54-4F2C-B0C0-A31032C31B3FQ33891868-988ABA20-E7E0-4E6E-B270-602CC291FED4Q33930224-74C62C41-4272-4A19-822C-5934F3856C9FQ34009569-16411BAC-575A-401E-BAFD-07159DD3BB63Q34367479-33ED6D15-D052-4961-AEFA-48E5CC2AFAE2Q34441705-54F60C6E-CA03-4253-9F8E-8C9D1A4A0667Q34576635-DCC2401C-1B03-4B09-862B-7C0887E7C68CQ35016295-66565284-ADD2-4BB2-8B3C-5010F1F3FE58Q35166767-C0C4EBAF-C9FD-4504-A1E6-B94DA9DE4777Q36008760-6D27DC27-EBB2-4828-AF98-631F349498A5Q36447553-6DE39D47-5AC4-4953-BC45-A3136F0D6984Q36491653-F16FB7E7-A898-4FF9-A6AD-BC716841D648Q36643023-6AC80BAC-6F20-459F-AE40-EB2196B2A782Q36672697-6A3C32E6-C482-46E2-9AE1-63F32D16EBB0Q36962776-3B492182-C452-44C8-9F8D-61426A8DA41DQ37079651-FC7BF764-19FD-46B6-A0F5-80939D8D62CEQ37392009-5AD73DF8-692D-46E0-92E1-96FCBACE7452Q37430395-E561BEDD-F487-457F-93B9-4F2971462BA6Q37460461-1C26BC5D-9F28-4048-A014-E5EEAB214D36Q37650334-0D57D64A-5BC0-4674-9CBA-6A71E372B374Q37670256-8A4D7DCD-862B-473B-A259-C9AC0FB60CE4Q37699431-3339E84B-B08A-4358-9434-66BBACD799C1Q38221612-DD0CDE1D-52CA-4484-84E7-9CB0CF24940AQ39093915-F380C643-54C3-43CC-A951-1210C014425FQ39129914-0770CB27-CB13-4DAE-8BFE-A26C345B7CEAQ40090151-6D425A7D-DDE9-47A9-9E5F-9590E31D4658Q40293083-A7E6084E-F6EB-4856-93B8-A977469D4D5AQ41351605-851D3419-96B0-4F62-BB69-7658D78A070DQ41470599-28C83F02-91CB-426A-BB80-F7C4FA97C001Q41829362-9E904787-2677-404D-A2D5-949B1F8513DDQ45953271-D11A290C-3246-4D66-9733-E091073C7E2DQ47140038-F40844C3-39B4-4AA4-A86C-2601C4883143Q50490101-F2262E00-03BC-4B51-BE72-22B451526425
P2860
From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
From molds and macrophages to ...... of action of bisphosphonates.
@ast
From molds and macrophages to ...... of action of bisphosphonates.
@en
type
label
From molds and macrophages to ...... of action of bisphosphonates.
@ast
From molds and macrophages to ...... of action of bisphosphonates.
@en
prefLabel
From molds and macrophages to ...... of action of bisphosphonates.
@ast
From molds and macrophages to ...... of action of bisphosphonates.
@en
P2860
P1476
From molds and macrophages to ...... e of action of bisphosphonates
@en
P2093
P2860
P2888
P304
P356
10.1007/S00223-004-0024-1
P407
P577
2004-08-31T00:00:00Z